Aug. 28 at 5:12 PM
$AEHR $ICHR Let’s pressure-test the pitch for ICHR (Ichor Holdings) and the “alt dark horse” AEHR. Short answer: for ICHR a near-term moonshot needs a fresh catalyst that isn’t on the tape yet. AEHR really did pop recently on AI orders—but its path still hinges on converting evals into volume. For ICHR an "Overlooked chokepoint” claim is mostly true: OEMs increasingly outsource gas/chemical subsystems to a few specialists; Ichor is one of them. Gas/chemistry complexity rises with HBM/2.5D/3D, so “content per tool” tends to creep up. That supports a cyclical up-leg as AI capex flows.A pop is plausible if Q3 commentary shows margin traction or visible new program wins, absent that, it skews grind-higher with the WFE cycle rather than “ticking time bomb.”
However, BUY recommendations for both.
